Sep 15, 2020
In typically dry Australian style, researchers from Tasmania recently introduced a study of curcumin extract for the management of knee OA by observing that current pharmacologic therapies for patients with osteoarthritis are sub-optimal. An understatement. The...
Sep 15, 2020
Acetylcholinesterase inhibitors (AChEis) include donepezil, galantamine and rivastigmine, and are used to manage cognitive decline associated with advancing dementia. A recent study evaluated evidence from case reports literature seeking to determine if there is an...
Sep 12, 2020
A recent American study has investigated whether the US Medicare Part D’s expansion of benzodiazepine coverage in 2013 was linked to an increased incidence of fall-related injuries and overdose in patients aged 65 years and over. Researchers used claims data from...
Sep 12, 2020
The problematic propensity of people with cancer having a much higher risk for VTE has long presented clinical challenges that have been difficult to address. The use of oral edoxaban or rivaroxaban has been recommended for treatment of venous thromboembolism in...
Sep 1, 2020
Direct oral anticoagulants (DOACs) are increasingly prescribed, in many cases in preference to warfarin treatment. A range of predictive scoring systems have been in use for some time to quantify (to some extent) the risk of serious bleeding associated with warfarin...
Aug 31, 2020
The ‘ASPirin in Reducing Events in the Elderly’, or ‘ASPREE’ study, was a randomised, controlled trial of aspirin versus placebo for prevention of CV events, between 2010-2017 by a team of researchers from Australia and the United States. Its aim was to address the...
